Induced pluripotent stem cells meet genome editing

Cell Stem Cell

Volumn 18, Issue 5, 2016, Pages 573-586

  Hockemeyer, Dirk ^a   Jaenisch, Rudolf ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; HUNTINGTIN; MESSENGER RNA; NUCLEASE;

CELL DIFFERENTIATION; CRISPR CAS SYSTEM; EPIGENETICS; GENETIC ASSOCIATION; HUMAN; HUMAN GENOME; INDUCED PLURIPOTENT STEM CELL; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REVIEW; CYTOLOGY; GENE EDITING; GENETIC EPIGENESIS; GENETICS; METABOLISM; NUCLEAR REPROGRAMMING;

CELLULAR REPROGRAMMING; CRISPR-CAS SYSTEMS; EPIGENESIS, GENETIC; GENE EDITING; GENOME, HUMAN; HUMANS; INDUCED PLURIPOTENT STEM CELLS;

EID: 84966930890     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2016.04.013     Document Type: Review

References (194)

1. D.J. Ambrosi, and T.P. Rasmussen Reprogramming mediated by stem cell fusion J. Cell. Mol. Med. 9 2005 320 330
2. M.C. An, N. Zhang, G. Scott, D. Montoro, T. Wittkop, S. Mooney, S. Melov, and L.M. Ellerby Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells Cell Stem Cell 11 2012 253 263
3. E. Apostolou, and K. Hochedlinger Chromatin dynamics during cellular reprogramming Nature 502 2013 462 471
4. T.O. Auer, K. Duroure, A. De Cian, J.P. Concordet, and F. Del Bene Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair Genome Res. 24 2014 142 153
5. Y. Avior, I. Sagi, and N. Benvenisty Pluripotent stem cells in disease modelling and drug discovery Nat. Rev. Mol. Cell Biol. 17 2016 170 182
6. A.R. Bassett, C. Tibbit, C.P. Ponting, and J.L. Liu Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system Cell Rep. 4 2013 220 228
7. F.B. Bedada, M. Wheelwright, and J.M. Metzger Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes Biochim. Biophys. Acta 2015 10.1016/j.bbamcr.2015.11.005 in press. Published online November 11, 2015
8. K.J. Beumer, J.K. Trautman, A. Bozas, J.L. Liu, J. Rutter, J.G. Gall, and D. Carroll Efficient gene targeting in Drosophila by direct embryo injection with zinc-finger nucleases Proc. Natl. Acad. Sci. USA 105 2008 19821 19826
9. M. Bibikova, M. Golic, K.G. Golic, and D. Carroll Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases Genetics 161 2002 1169 1175
10. M. Bibikova, K. Beumer, J.K. Trautman, and D. Carroll Enhancing gene targeting with designed zinc finger nucleases Science 300 2003 764
11. J.D. Blair, H.S. Bateup, and D.F. Hockemeyer Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation J. Vis. Exp. 108 2016
12. S.E. Bojesen, K.A. Pooley, S.E. Johnatty, J. Beesley, K. Michailidou, J.P. Tyrer, S.L. Edwards, H.A. Pickett, H.C. Shen, C.E. Smart, and et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer Nat. Genet. 45 2013 371 384 384e371-372
13. I.G. Brons, L.E. Smithers, M.W. Trotter, P. Rugg-Gunn, B. Sun, S.M. Chuva de Sousa Lopes, S.K. Howlett, A. Clarkson, L. Ahrlund-Richter, R.A. Pedersen, and L. Vallier Derivation of pluripotent epiblast stem cells from mammalian embryos Nature 448 2007 191 195
14. Y. Buganim, D.A. Faddah, A.W. Cheng, E. Itskovich, S. Markoulaki, K. Ganz, S.L. Klemm, A. van Oudenaarden, and R. Jaenisch Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase Cell 150 2012 1209 1222
15. S.M. Byrne, and G.M. Church Crispr-mediated Gene Targeting of Human Induced Pluripotent Stem Cells Curr. Protoc. Stem Cell Biol. 35 2015 5a.8.1-22
16. E. Callaway Microsoft billionaire takes on cell biology Nature 516 2014 157
17. K.H. Campbell, J. McWhir, W.A. Ritchie, and I. Wilmut Sheep cloned by nuclear transfer from a cultured cell line Nature 380 1996 64 66
18. D. Carroll Genome engineering with targetable nucleases Annu. Rev. Biochem. 83 2014 409 439
19. N. Chang, C. Sun, L. Gao, D. Zhu, X. Xu, X. Zhu, J.W. Xiong, and J.J. Xi Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos Cell Res. 23 2013 465 472
20. J.R. Chapman, M.R. Taylor, and S.J. Boulton Playing the end game: DNA double-strand break repair pathway choice Mol. Cell 47 2012 497 510
21. F. Chen, S.M. Pruett-Miller, Y. Huang, M. Gjoka, K. Duda, J. Taunton, T.N. Collingwood, M. Frodin, and G.D. Davis High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases Nat. Methods 8 2011 753 755
22. B. Chen, L.A. Gilbert, B.A. Cimini, J. Schnitzbauer, W. Zhang, G.W. Li, J. Park, E.H. Blackburn, J.S. Weissman, L.S. Qi, and B. Huang Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system Cell 155 2013 1479 1491
23. Y. Chen, J. Cao, M. Xiong, A.J. Petersen, Y. Dong, Y. Tao, C.T. Huang, Z. Du, and S.C. Zhang Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9 Cell Stem Cell 17 2015 233 244
24. J.R. Chen, Z.H. Tang, J. Zheng, H.S. Shi, J. Ding, X.D. Qian, C. Zhang, J.L. Chen, C.C. Wang, L. Li, and et al. Effects of genetic correction on the differentiation of hair cell-like cells from iPSCs with MYO15A mutation Cell Death Differ. 2016 10.1038/cdd.2016.16 in press. Published online February 26, 2016
25. K. Chiba, and D. Hockemeyer Genome editing in human pluripotent stem cells using site-specific nucleases Methods Mol. Biol. 1239 2015 267 280
26. K. Chiba, J.Z. Johnson, J.M. Vogan, T. Wagner, J.M. Boyle, and D. Hockemeyer Cancer-associated TERT promoter mutations abrogate telomerase silencing eLife 4 2015 4
27. V.T. Chu, T. Weber, B. Wefers, W. Wurst, S. Sander, K. Rajewsky, and R. Kühn Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells Nat. Biotechnol. 33 2015 543 548
28. C.Y. Chung, V. Khurana, P.K. Auluck, D.F. Tardiff, J.R. Mazzulli, F. Soldner, V. Baru, Y. Lou, Y. Freyzon, S. Cho, and et al. Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons Science 342 2013 983 987
29. L. Cong, F.A. Ran, D. Cox, S. Lin, R. Barretto, N. Habib, P.D. Hsu, X. Wu, W. Jiang, L.A. Marraffini, and F. Zhang Multiplex genome engineering using CRISPR/Cas systems Science 339 2013 819 823
30. M. Costa, M. Dottori, K. Sourris, P. Jamshidi, T. Hatzistavrou, R. Davis, L. Azzola, S. Jackson, S.M. Lim, M. Pera, and et al. A method for genetic modification of human embryonic stem cells using electroporation Nat. Protoc. 2 2007 792 796
31. A.M. Crane, P. Kramer, J.H. Bui, W.J. Chung, X.S. Li, M.L. Gonzalez-Garay, F. Hawkins, W. Liao, D. Mora, S. Choi, and et al. Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells Stem Cell Reports 4 2015 569 577
32. N. Crosetto, A. Mitra, M.J. Silva, M. Bienko, N. Dojer, Q. Wang, E. Karaca, R. Chiarle, M. Skrzypczak, K. Ginalski, and et al. Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing Nat. Methods 10 2013 361 365
33. R.P. Davis, M. Costa, C. Grandela, A.M. Holland, T. Hatzistavrou, S.J. Micallef, X. Li, A.L. Goulburn, L. Azzola, A.G. Elefanty, and E.G. Stanley A protocol for removal of antibiotic resistance cassettes from human embryonic stem cells genetically modified by homologous recombination or transgenesis Nat. Protoc. 3 2008 1550 1558
34. R.P. Davis, E.S. Ng, M. Costa, A.K. Mossman, K. Sourris, A.G. Elefanty, and E.G. Stanley Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors Blood 111 2008 1876 1884
35. R.C. DeKelver, V.M. Choi, E.A. Moehle, D.E. Paschon, D. Hockemeyer, S.H. Meijsing, Y. Sancak, X. Cui, E.J. Steine, J.C. Miller, and et al. Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome Genome Res. 20 2010 1133 1142
36. D.J. Dickinson, J.D. Ward, D.J. Reiner, and B. Goldstein Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination Nat. Methods 10 2013 1028 1034
37. T. Doetschman, R.G. Gregg, N. Maeda, M.L. Hooper, D.W. Melton, S. Thompson, and O. Smithies Targetted correction of a mutant HPRT gene in mouse embryonic stem cells Nature 330 1987 576 578
38. B. Elliott, C. Richardson, J. Winderbaum, J.A. Nickoloff, and M. Jasin Gene conversion tracts from double-strand break repair in mammalian cells Mol. Cell. Biol. 18 1998 93 101
39. M.J. Evans, and M.H. Kaufman Establishment in culture of pluripotential cells from mouse embryos Nature 292 1981 154 156
40. A.L. Firth, T. Menon, G.S. Parker, S.J. Qualls, B.M. Lewis, E. Ke, C.T. Dargitz, R. Wright, A. Khanna, F.H. Gage, and I.M. Verma Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs Cell Rep. 12 2015 1385 1390
41. R. Forster, K. Chiba, L. Schaeffer, S.G. Regalado, C.S. Lai, Q. Gao, S. Kiani, H.F. Farin, H. Clevers, G.J. Cost, and et al. Human intestinal tissue with adult stem cell properties derived from pluripotent stem cells Stem Cell Reports 2 2014 838 852
42. N.J. Fredriksson, L. Ny, J.A. Nilsson, and E. Larsson Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types Nat. Genet. 46 2014 1258 1263
43. R.L. Frock, J. Hu, R.M. Meyers, Y.J. Ho, and E. Kii Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases Nat. Biotechnol. 33 2015 179 186
44. Y. Fu, J.A. Foden, C. Khayter, M.L. Maeder, D. Reyon, J.K. Joung, and J.D. Sander High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells Nat. Biotechnol. 31 2013 822 826
45. Y. Fu, J.D. Sander, D. Reyon, V.M. Cascio, and J.K. Joung Improving CRISPR-Cas nuclease specificity using truncated guide RNAs Nat. Biotechnol. 32 2014 279 284
46. N. Fusaki, H. Ban, A. Nishiyama, K. Saeki, and M. Hasegawa Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci. 85 2009 348 362
47. R. Gabriel, A. Lombardo, A. Arens, J.C. Miller, P. Genovese, C. Kaeppel, A. Nowrouzi, C.C. Bartholomae, J. Wang, G. Friedman, and et al. An unbiased genome-wide analysis of zinc-finger nuclease specificity Nat. Biotechnol. 29 2011 816 823
48. G. Gibson Rare and common variants: twenty arguments Nat. Rev. Genet. 13 2011 135 145
49. L.A. Gilbert, M.A. Horlbeck, B. Adamson, J.E. Villalta, Y. Chen, E.H. Whitehead, C. Guimaraes, B. Panning, H.L. Ploegh, M.C. Bassik, and et al. Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation Cell 159 2014 647 661
50. F. González, Z. Zhu, Z.D. Shi, K. Lelli, N. Verma, Q.V. Li, and D. Huangfu An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells Cell Stem Cell 15 2014 215 226
51. S.J. Gratz, A.M. Cummings, J.N. Nguyen, D.C. Hamm, L.K. Donohue, M.M. Harrison, J. Wildonger, and K.M. O'Connor-Giles Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease Genetics 194 2013 1029 1035
52. M.G. Guenther, G.M. Frampton, F. Soldner, D. Hockemeyer, M. Mitalipova, R. Jaenisch, and R.A. Young Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells Cell Stem Cell 7 2010 249 257
53. Y. Guo, Q. Xu, D. Canzio, J. Shou, J. Li, D.U. Gorkin, I. Jung, H. Wu, Y. Zhai, Y. Tang, and et al. CRISPR Inversion of CTCF Sites Alters Genome Topology and Enhancer/Promoter Function Cell 162 2015 900 910
54. J.B. Gurdon The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles J. Embryol. Exp. Morphol. 10 1962 622 640
55. J. Gurdon Nuclear transplantation in Amphibia and the importance of stable nuclear changes in cellular differentiation Q. Rev. Biol. 38 1963 54 78
56. T. Hart, M. Chandrashekhar, M. Aregger, Z. Steinhart, K.R. Brown, G. MacLeod, M. Mis, M. Zimmermann, A. Fradet-Turcotte, S. Sun, and et al. High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities Cell 163 2015 1515 1526
57. K. Hochedlinger, and R. Jaenisch Monoclonal mice generated by nuclear transfer from mature B and T donor cells Nature 415 2002 1035 1038
58. D. Hockemeyer, and R. Jaenisch Gene targeting in human pluripotent cells Cold Spring Harb. Symp. Quant. Biol. 75 2010 201 209
59. D. Hockemeyer, F. Soldner, C. Beard, Q. Gao, M. Mitalipova, R.C. DeKelver, G.E. Katibah, R. Amora, E.A. Boydston, B. Zeitler, and et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases Nat. Biotechnol. 27 2009 851 857
60. D. Hockemeyer, H. Wang, S. Kiani, C.S. Lai, Q. Gao, J.P. Cassady, G.J. Cost, L. Zhang, Y. Santiago, J.C. Miller, and et al. Genetic engineering of human pluripotent cells using TALE nucleases Nat. Biotechnol. 29 2011 731 734
61. S. Horn, A. Figl, P.S. Rachakonda, C. Fischer, A. Sucker, A. Gast, S. Kadel, I. Moll, E. Nagore, K. Hemminki, and et al. TERT promoter mutations in familial and sporadic melanoma Science 339 2013 959 961
62. Z. Hou, Y. Zhang, N.E. Propson, S.E. Howden, L.F. Chu, E.J. Sontheimer, and J.A. Thomson Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis Proc. Natl. Acad. Sci. USA 110 2013 15644 15649
63. S.E. Howden, A. Gore, Z. Li, H.L. Fung, B.S. Nisler, J. Nie, G. Chen, B.E. McIntosh, D.R. Gulbranson, N.R. Diol, and et al. Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy Proc. Natl. Acad. Sci. USA 108 2011 6537 6542
64. S.E. Howden, J.P. Maufort, B.M. Duffin, A.G. Elefanty, E.G. Stanley, and J.A. Thomson Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts Stem Cell Reports 5 2015 1109 1118
65. S. Hrvatin, C.W. O'Donnell, F. Deng, J.R. Millman, F.W. Pagliuca, P. DiIorio, A. Rezania, D.K. Gifford, and D.A. Melton Differentiated human stem cells resemble fetal, not adult, β cells Proc. Natl. Acad. Sci. USA 111 2014 3038 3043
66. P.D. Hsu, E.S. Lander, and F. Zhang Development and applications of CRISPR-Cas9 for genome engineering Cell 157 2014 1262 1278
67. F.W. Huang, E. Hodis, M.J. Xu, G.V. Kryukov, L. Chin, and L.A. Garraway Highly recurrent TERT promoter mutations in human melanoma Science 339 2013 957 959
68. P.D. Hsu, D.A. Scott, J.A. Weinstein, F.A. Ran, S. Konermann, V. Agarwala, Y. Li, E.J. Fine, X. Wu, O. Shalem, and et al. DNA targeting specificity of RNA-guided Cas9 nucleases Nat. Biotechnol. 31 2013 827 832
69. W.Y. Hwang, Y. Fu, D. Reyon, M.L. Maeder, P. Kaini, J.D. Sander, J.K. Joung, R.T. Peterson, and J.R. Yeh Heritable and precise zebrafish genome editing using a CRISPR-Cas system PLoS ONE 8 2013 e68708
70. W.Y. Hwang, Y. Fu, D. Reyon, M.L. Maeder, S.Q. Tsai, J.D. Sander, R.T. Peterson, J.R. Yeh, and J.K. Joung Efficient genome editing in zebrafish using a CRISPR-Cas system Nat. Biotechnol. 31 2013 227 229
71. S. Irion, H. Luche, P. Gadue, H.J. Fehling, M. Kennedy, and G. Keller Identification and targeting of the ROSA26 locus in human embryonic stem cells Nat. Biotechnol. 25 2007 1477 1482
72. J. Jiang, Y. Jing, G.J. Cost, J.C. Chiang, H.J. Kolpa, A.M. Cotton, D.M. Carone, B.R. Carone, D.A. Shivak, D.Y. Guschin, and et al. Translating dosage compensation to trisomy 21 Nature 500 2013 296 300
73. M. Jinek, K. Chylinski, I. Fonfara, M. Hauer, J.A. Doudna, and E. Charpentier A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity Science 337 2012 816 821
74. J.Z. Johnson, and D. Hockemeyer Human stem cell-based disease modeling: prospects and challenges Curr. Opin. Cell Biol. 37 2015 84 90
75. K. Kaji, K. Norrby, A. Paca, M. Mileikovsky, P. Mohseni, and K. Woltjen Virus-free induction of pluripotency and subsequent excision of reprogramming factors Nature 458 2009 771 775
76. L. Kang, J. Wang, Y. Zhang, Z. Kou, and S. Gao iPS cells can support full-term development of tetraploid blastocyst-complemented embryos Cell Stem Cell 5 2009 135 138
77. X. Kang, W. He, Y. Huang, Q. Yu, Y. Chen, X. Gao, X. Sun, and Y. Fan Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing J. Assist. Reprod. Genet. 2016 10.1007/s10815-016-0710-8 in press April 6, 2016
78. P.J. Killela, Z.J. Reitman, Y. Jiao, C. Bettegowda, N. Agrawal, L.A. Diaz Jr., A.H. Friedman, H. Friedman, G.L. Gallia, B.C. Giovanella, and et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal Proc. Natl. Acad. Sci. USA 110 2013 6021 6026
79. D. Kim, C.H. Kim, J.I. Moon, Y.G. Chung, M.Y. Chang, B.S. Han, S. Ko, E. Yang, K.Y. Cha, R. Lanza, and K.S. Kim Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins Cell Stem Cell 4 2009 472 476
80. K. Kim, A. Doi, B. Wen, K. Ng, R. Zhao, P. Cahan, J. Kim, M.J. Aryee, H. Ji, L.I.R. Ehrlich, and et al. Epigenetic memory in induced pluripotent stem cells Nature 467 2010 285 290
81. B.P. Kleinstiver, M.S. Prew, S.Q. Tsai, V.V. Topkar, N.T. Nguyen, Z. Zheng, A.P. Gonzales, Z. Li, R.T. Peterson, J.R. Yeh, and et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities Nature 523 2015 481 485
82. B.P. Kleinstiver, M.S. Prew, S.Q. Tsai, N.T. Nguyen, V.V. Topkar, Z. Zheng, and J.K. Joung Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition Nat. Biotechnol. 33 2015 1293 1298
83. B.P. Kleinstiver, M.S. Prew, S.Q. Tsai, V.V. Topkar, N.T. Nguyen, Z. Zheng, A.P. Gonzales, Z. Li, R.T. Peterson, J.R. Yeh, and et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities Nature 523 2015 481 485
84. B.P. Kleinstiver, V. Pattanayak, M.S. Prew, S.Q. Tsai, N.T. Nguyen, Z. Zheng, and J.K. Joung High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects Nature 529 2016 490 495
85. S.C. Knight, L. Xie, W. Deng, B. Guglielmi, L.B. Witkowsky, L. Bosanac, E.T. Zhang, M. El Beheiry, J.B. Masson, M. Dahan, and et al. Dynamics of CRISPR-Cas9 genome interrogation in living cells Science 350 2015 823 826
86. S. Konermann, M.D. Brigham, A.E. Trevino, J. Joung, O.O. Abudayyeh, C. Barcena, P.D. Hsu, N. Habib, J.S. Gootenberg, H. Nishimasu, and et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex Nature 517 2015 583 588
87. A.G. Kotini, C.J. Chang, I. Boussaad, J.J. Delrow, E.K. Dolezal, A.B. Nagulapally, F. Perna, G.A. Fishbein, V.M. Klimek, R.D. Hawkins, and et al. Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells Nat. Biotechnol. 33 2015 646 655
88. A. Kyttälä, R. Moraghebi, C. Valensisi, J. Kettunen, C. Andrus, K.K. Pasumarthy, M. Nakanishi, K. Nishimura, M. Ohtaka, J. Weltner, and et al. Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential Stem Cell Reports 6 2016 200 212
89. M.A. Lancaster, and J.A. Knoblich Organogenesis in a dish: modeling development and disease using organoid technologies Science 345 2014 1247125
90. M.A. Lancaster, M. Renner, C.A. Martin, D. Wenzel, L.S. Bicknell, M.E. Hurles, T. Homfray, J.M. Penninger, A.P. Jackson, and J.A. Knoblich Cerebral organoids model human brain development and microcephaly Nature 501 2013 373 379
91. Y. Li, H. Wang, J. Muffat, A.W. Cheng, D.A. Orlando, J. Lovén, S.M. Kwok, D.A. Feldman, H.S. Bateup, Q. Gao, and et al. Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons Cell Stem Cell 13 2013 446 458
92. P. Liang, Y. Xu, X. Zhang, C. Ding, R. Huang, Z. Zhang, J. Lv, X. Xie, Y. Chen, Y. Li, and et al. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes Protein Cell 6 2015 363 372
93. J. Liao, and R. Karnik Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells Nat. Genet. 47 2015 469 478
94. S. Lin, B.T. Staahl, R.K. Alla, and J.A. Doudna Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery eLife 3 2014 e04766
95. A. Lombardo, P. Genovese, C.M. Beausejour, S. Colleoni, Y.L. Lee, K.A. Kim, D. Ando, F.D. Urnov, C. Galli, P.D. Gregory, and et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery Nat. Biotechnol. 25 2007 1298 1306
96. N. Ma, B. Liao, H. Zhang, L. Wang, Y. Shan, Y. Xue, K. Huang, S. Chen, X. Zhou, Y. Chen, and et al. Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free β-thalassemia induced pluripotent stem cells J. Biol. Chem. 288 2013 34671 34679
97. M.L. Maeder, J.F. Angstman, M.E. Richardson, S.J. Linder, V.M. Cascio, S.Q. Tsai, Q.H. Ho, J.D. Sander, D. Reyon, B.E. Bernstein, and et al. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins Nat. Biotechnol. 31 2013 1137 1142
98. D. Maetzel, S. Sarkar, H. Wang, L. Abi-Mosleh, P. Xu, A.W. Cheng, Q. Gao, M. Mitalipova, and R. Jaenisch Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells Stem Cell Reports 2 2014 866 880
99. N. Maherali, R. Sridharan, W. Xie, J. Utikal, S. Eminli, K. Arnold, M. Stadtfeld, R. Yachechko, J. Tchieu, R. Jaenisch, and et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution Cell Stem Cell 1 2007 55 70
100. P. Mali, L. Yang, K.M. Esvelt, J. Aach, M. Guell, J.E. DiCarlo, J.E. Norville, and G.M. Church RNA-guided human genome engineering via Cas9 Science 339 2013 823 826
101. M.A. Mandegar, N. Huebsch, E.B. Frolov, E. Shin, A. Truong, M.P. Olvera, A.H. Chan, Y. Miyaoka, K. Holmes, C.I. Spencer, and et al. CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs Cell Stem Cell 18 2016 541 553
102. L.A. Marraffini CRISPR-Cas immunity in prokaryotes Nature 526 2015 55 61
103. G.R. Martin Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells Proc. Natl. Acad. Sci. USA 78 1981 7634 7638
104. T. Maruyama, S.K. Dougan, M.C. Truttmann, A.M. Bilate, J.R. Ingram, and H.L. Ploegh Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining Nat. Biotechnol. 33 2015 538 542
105. M. Matano, S. Date, M. Shimokawa, A. Takano, M. Fujii, Y. Ohta, T. Watanabe, T. Kanai, and T. Sato Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids Nat. Med. 21 2015 256 262
106. G.E. Meister, S. Chandrasegaran, and M. Ostermeier Heterodimeric DNA methyltransferases as a platform for creating designer zinc finger methyltransferases for targeted DNA methylation in cells Nucleic Acids Res. 38 2010 1749 1759
107. F.T. Merkle, and K. Eggan Modeling human disease with pluripotent stem cells: from genome association to function Cell Stem Cell 12 2013 656 668
108. J.D. Miller, Y.M. Ganat, S. Kishinevsky, R.L. Bowman, B. Liu, E.Y. Tu, P.K. Mandal, E. Vera, J.W. Shim, S. Kriks, and et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging Cell Stem Cell 13 2013 691 705
109. Y. Miyaoka, A.H. Chan, L.M. Judge, J. Yoo, M. Huang, T.D. Nguyen, P.P. Lizarraga, P.L. So, and B.R. Conklin Isolation of single-base genome-edited human iPS cells without antibiotic selection Nat. Methods 11 2014 291 293
110. J. Morton, M.W. Davis, E.M. Jorgensen, and D. Carroll Induction and repair of zinc-finger nuclease-targeted double-strand breaks in Caenorhabditis elegans somatic cells Proc. Natl. Acad. Sci. USA 103 2006 16370 16375
111. D.A. Nelles, M.Y. Fang, M.R. O'Connell, J.L. Xu, S.J. Markmiller, J.A. Doudna, and G.W. Yeo Programmable RNA Tracking in Live Cells with CRISPR/Cas9 Cell 165 2016 488 496
112. J. Nichols, and A. Smith Naive and primed pluripotent states Cell Stem Cell 4 2009 487 492
113. Y. Niu, B. Shen, Y. Cui, Y. Chen, J. Wang, L. Wang, Y. Kang, X. Zhao, W. Si, W. Li, and et al. Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos Cell 156 2014 836 843
114. M.R. O'Connell, B.L. Oakes, S.H. Sternberg, A. East-Seletsky, M. Kaplan, and J.A. Doudna Programmable RNA recognition and cleavage by CRISPR/Cas9 Nature 516 2014 263 266
115. K. Okita, T. Ichisaka, and S. Yamanaka Generation of germline-competent induced pluripotent stem cells Nature 448 2007 313 317
116. I.H. Park, R. Zhao, J.A. West, A. Yabuuchi, H. Huo, T.A. Ince, P.H. Lerou, M.W. Lensch, and G.Q. Daley Reprogramming of human somatic cells to pluripotency with defined factors Nature 451 2008 141 146
117. C.Y. Park, D.H. Kim, J.S. Son, J.J. Sung, J. Lee, S. Bae, J.H. Kim, D.W. Kim, and J.S. Kim Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9 Cell Stem Cell 17 2015 213 220
118. O. Parnas, M. Jovanovic, T.M. Eisenhaure, R.H. Herbst, A. Dixit, C.J. Ye, D. Przybylski, R.J. Platt, I. Tirosh, N.E. Sanjana, and et al. A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks Cell 162 2015 675 686
119. J.M. Polo, S. Liu, M.E. Figueroa, W. Kulalert, S. Eminli, K.Y. Tan, E. Apostolou, M. Stadtfeld, Y. Li, T. Shioda, and et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells Nat. Biotechnol. 28 2010 848 855
120. F.A. Ran, L. Cong, W.X. Yan, D.A. Scott, J.S. Gootenberg, A.J. Kriz, B. Zetsche, O. Shalem, X. Wu, K.S. Makarova, and et al. In vivo genome editing using Staphylococcus aureus Cas9 Nature 520 2015 186 191
121. P. Reinhardt, B. Schmid, L.F. Burbulla, D.C. Schöndorf, L. Wagner, M. Glatza, S. Höing, G. Hargus, S.A. Heck, A. Dhingra, and et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression Cell Stem Cell 12 2013 354 367
122. W.M. Rideout 3rd, K. Hochedlinger, M. Kyba, G.Q. Daley, and R. Jaenisch Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy Cell 109 2002 17 27
123. F. Robert, M. Barbeau, S. Éthier, J. Dostie, and J. Pelletier Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing Genome Med. 7 2015 93
124. D.A. Robinton, and G.Q. Daley The promise of induced pluripotent stem cells in research and therapy Nature 481 2012 295 305
125. P. Rouet, F. Smih, and M. Jasin Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells Proc. Natl. Acad. Sci. USA 91 1994 6064 6068
126. P. Rouet, F. Smih, and M. Jasin Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease Mol. Cell. Biol. 14 1994 8096 8106
127. F. Rouhani, N. Kumasaka, M.C. de Brito, A. Bradley, L. Vallier, and D. Gaffney Genetic background drives transcriptional variation in human induced pluripotent stem cells PLoS Genet. 10 2014 e1004432
128. K.M. Ruby, and B. Zheng Gene targeting in a HUES line of human embryonic stem cells via electroporation Stem Cells 27 2009 1496 1506
129. S.D. Ryan, N. Dolatabadi, S.F. Chan, X. Zhang, M.W. Akhtar, J. Parker, F. Soldner, C.R. Sunico, S. Nagar, M. Talantova, and et al. Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription Cell 155 2013 1351 1364
130. T. Sato, and H. Clevers Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications Science 340 2013 1190 1194
131. T. Sato, R.G. Vries, H.J. Snippert, M. van de Wetering, N. Barker, D.E. Stange, J.H. van Es, A. Abo, P. Kujala, P.J. Peters, and H. Clevers Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche Nature 459 2009 262 265
132. T. Sato, D.E. Stange, M. Ferrante, R.G. Vries, J.H. Van Es, S. Van den Brink, W.J. Van Houdt, A. Pronk, J. Van Gorp, P.D. Siersema, and H. Clevers Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium Gastroenterology 141 2011 1762 1772
133. G. Schwank, B.K. Koo, V. Sasselli, J.F. Dekkers, I. Heo, T. Demircan, N. Sasaki, S. Boymans, E. Cuppen, C.K. van der Ent, and et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients Cell Stem Cell 13 2013 653 658
134. V. Sebastiano, H.H. Zhen, B. Haddad, E. Bashkirova, S.P. Melo, P. Wang, T.L. Leung, Z. Siprashvili, A. Tichy, J. Li, and et al. Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa Sci. Transl. Med. 6 2014 264ra163
135. A.N. Sexton, S.G. Regalado, C.S. Lai, G.J. Cost, C.M. O'Neil, F.D. Urnov, P.D. Gregory, R. Jaenisch, K. Collins, and D. Hockemeyer Genetic and molecular identification of three human TPP1 functions in telomerase action: recruitment, activation, and homeostasis set point regulation Genes Dev. 28 2014 1885 1899
136. O. Shalem, N.E. Sanjana, E. Hartenian, X. Shi, D.A. Scott, T.S. Mikkelsen, D. Heckl, B.L. Ebert, D.E. Root, J.G. Doench, and F. Zhang Genome-scale CRISPR-Cas9 knockout screening in human cells Science 343 2014 84 87
137. C. Sheridan CRISPR germline editing reverberates through biotech industry Nat. Biotechnol. 33 2015 431 432
138. J. Shi, Y. Zhao, K. Wang, X. Shi, Y. Wang, H. Huang, Y. Zhuang, T. Cai, F. Wang, and F. Shao Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death Nature 526 2015 660 665
139. I.M. Slaymaker, L. Gao, B. Zetsche, D.A. Scott, W.X. Yan, and F. Zhang Rationally engineered Cas9 nucleases with improved specificity Science 351 2016 84 88
140. C. Smith, A. Gore, W. Yan, L. Abalde-Atristain, Z. Li, C. He, Y. Wang, R.A. Brodsky, K. Zhang, L. Cheng, and Z. Ye Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs Cell Stem Cell 15 2014 12 13
141. F. Soldner, and R. Jaenisch Medicine. iPSC disease modeling Science 338 2012 1155 1156
142. F. Soldner, D. Hockemeyer, C. Beard, Q. Gao, G.W. Bell, E.G. Cook, G. Hargus, A. Blak, O. Cooper, M. Mitalipova, and et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors Cell 136 2009 964 977
143. F. Soldner, J. Laganière, A.W. Cheng, D. Hockemeyer, Q. Gao, R. Alagappan, V. Khurana, L.I. Golbe, R.H. Myers, S. Lindquist, and et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations Cell 146 2011 318 331
144. F. Soldner, Y. Stelzer, C. Shivalila, B. Abraham, J. Latourelle, I. Barrasa, J.J. Goldmann, R. Myers, R. Young, and R. Jaenisch Parkinson-associated risk variant in enhancer element produces subtle effect on target gene expression Nature 2016 10.1038/nature17939 in press. Published online April 20, 2016
145. J.R. Spence, C.N. Mayhew, S.A. Rankin, M.F. Kuhar, J.E. Vallance, K. Tolle, E.E. Hoskins, V.V. Kalinichenko, S.I. Wells, A.M. Zorn, and et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro Nature 470 2011 105 109
146. J.L. Sterneckert, P. Reinhardt, and H.R. Schöler Investigating human disease using stem cell models Nat. Rev. Genet. 15 2014 625 639
147. L. Studer, E. Vera, and D. Cornacchia Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency Cell Stem Cell 16 2015 591 600
148. S. Suzuki, R.G. Sargent, B. Illek, H. Fischer, A. Esmaeili-Shandiz, M.J. Yezzi, A. Lee, Y. Yang, S. Kim, P. Renz, and et al. TALENs Facilitate Single-step Seamless SDF Correction of F508del CFTR in Airway Epithelial Submucosal Gland Cell-derived CF-iPSCs Mol. Ther. Nucleic Acids 5 2016 e273
149. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
150. K. Takahashi, and S. Yamanaka A developmental framework for induced pluripotency Development 142 2015 3274 3285
151. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
152. T. Takebe, K. Sekine, M. Enomura, H. Koike, M. Kimura, T. Ogaeri, R.R. Zhang, Y. Ueno, Y.W. Zheng, N. Koike, and et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant Nature 499 2013 481 484
153. M.E. Tanenbaum, L.A. Gilbert, L.S. Qi, J.S. Weissman, and R.D. Vale A protein-tagging system for signal amplification in gene expression and fluorescence imaging Cell 159 2014 635 646
154. P. Tebas, D. Stein, W.W. Tang, I. Frank, S.Q. Wang, G. Lee, S.K. Spratt, R.T. Surosky, M.A. Giedlin, G. Nichol, and et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV N. Engl. J. Med. 370 2014 901 910
155. P.J. Tesar, J.G. Chenoweth, F.A. Brook, T.J. Davies, E.P. Evans, D.L. Mack, R.L. Gardner, and R.D. McKay New cell lines from mouse epiblast share defining features with human embryonic stem cells Nature 448 2007 196 199
156. T.W. Theunissen, B.E. Powell, H. Wang, M. Mitalipova, D.A. Faddah, J. Reddy, Z.P. Fan, D. Maetzel, K. Ganz, L. Shi, and et al. Systematic identification of culture conditions for induction and maintenance of naive human pluripotency Cell Stem Cell 15 2014 471 487
157. K.R. Thomas, and M.R. Capecchi Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells Cell 51 1987 503 512
158. J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, and J.M. Jones Embryonic stem cell lines derived from human blastocysts Science 282 1998 1145 1147
159. S.Q. Tsai, N. Wyvekens, C. Khayter, J.A. Foden, V. Thapar, D. Reyon, M.J. Goodwin, M.J. Aryee, and J.K. Joung Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing Nat. Biotechnol. 32 2014 569 576
160. S.Q. Tsai, Z. Zheng, N.T. Nguyen, M. Liebers, V.V. Topkar, V. Thapar, N. Wyvekens, C. Khayter, A.J. Iafrate, L.P. Le, and et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases Nat. Biotechnol. 33 2015 187 197
161. A. Urbach, M. Schuldiner, and N. Benvenisty Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells Stem Cells 22 2004 635 641
162. F.D. Urnov, J.C. Miller, Y.L. Lee, C.M. Beausejour, J.M. Rock, S. Augustus, A.C. Jamieson, M.H. Porteus, P.D. Gregory, and M.C. Holmes Highly efficient endogenous human gene correction using designed zinc-finger nucleases Nature 435 2005 646 651
163. F.D. Urnov, E.J. Rebar, M.C. Holmes, H.S. Zhang, and P.D. Gregory Genome editing with engineered zinc finger nucleases Nat. Rev. Genet. 11 2010 636 646
164. H. Wang, H. Yang, C.S. Shivalila, M.M. Dawlaty, A.W. Cheng, F. Zhang, and R. Jaenisch One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering Cell 153 2013 910 918
165. T. Wang, J.J. Wei, D.M. Sabatini, and E.S. Lander Genetic screens in human cells using the CRISPR-Cas9 system Science 343 2014 80 84
166. Y. Wang, P. Liang, F. Lan, H. Wu, L. Lisowski, M. Gu, S. Hu, M.A. Kay, F.D. Urnov, R. Shinnawi, and et al. Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing J. Am. Coll. Cardiol. 64 2014 451 459
167. T. Wang, K. Birsoy, N.W. Hughes, K.M. Krupczak, Y. Post, J.J. Wei, E.S. Lander, and D.M. Sabatini Identification and characterization of essential genes in the human genome Science 350 2015 1096 1101
168. X. Wang, Y. Wang, X. Wu, J. Wang, Y. Wang, Z. Qiu, T. Chang, H. Huang, R.J. Lin, and J.K. Yee Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors Nat. Biotechnol. 33 2015 175 178
169. L. Warren, P.D. Manos, T. Ahfeldt, Y.H. Loh, H. Li, F. Lau, W. Ebina, P.K. Mandal, Z.D. Smith, A. Meissner, and et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA Cell Stem Cell 7 2010 618 630
170. K. Watanabe, M. Ueno, D. Kamiya, A. Nishiyama, M. Matsumura, T. Wataya, J.B. Takahashi, S. Nishikawa, S. Nishikawa, K. Muguruma, and Y. Sasai A ROCK inhibitor permits survival of dissociated human embryonic stem cells Nat. Biotechnol. 25 2007 681 686
171. M. Wernig, A. Meissner, R. Foreman, T. Brambrink, M. Ku, K. Hochedlinger, B.E. Bernstein, and R. Jaenisch In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state Nature 448 2007 318 324
172. K. Woltjen, I.P. Michael, P. Mohseni, R. Desai, M. Mileikovsky, R. Hämäläinen, R. Cowling, W. Wang, P. Liu, M. Gertsenstein, and et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells Nature 458 2009 766 770
173. A.J. Wood, T.W. Lo, B. Zeitler, C.S. Pickle, E.J. Ralston, A.H. Lee, R. Amora, J.C. Miller, E. Leung, X. Meng, and et al. Targeted genome editing across species using ZFNs and TALENs Science 333 2011 307
174. X. Wu, A.J. Kriz, and P.A. Sharp Target specificity of the CRISPR-Cas9 system Quant. Biol. 2 2014 59 70
175. X. Wu, D.A. Scott, A.J. Kriz, A.C. Chiu, P.D. Hsu, D.B. Dadon, A.W. Cheng, A.E. Trevino, S. Konermann, S. Chen, and et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells Nat. Biotechnol. 32 2014 670 676
176. F. Xie, L. Ye, J.C. Chang, A.I. Beyer, J. Wang, M.O. Muench, and Y.W. Kan Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac Genome Res. 24 2014 1526 1533
177. H. Xue, S. Wu, S.T. Papadeas, S. Spusta, A.M. Swistowska, C.C. MacArthur, M.P. Mattson, N.J. Maragakis, M.R. Capecchi, M.S. Rao, and et al. A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells Stem Cells 27 2009 1836 1846
178. M. Yamada, B. Johannesson, I. Sagi, L.C. Burnett, D.H. Kort, R.W. Prosser, D. Paull, M.W. Nestor, M. Freeby, E. Greenberg, and et al. Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells Nature 510 2014 533 536
179. H. Yang, H. Wang, C.S. Shivalila, A.W. Cheng, L. Shi, and R. Jaenisch One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering Cell 154 2013 1370 1379
180. L. Ye, J. Wang, A.I. Beyer, F. Teque, T.J. Cradick, Z. Qi, J.C. Chang, G. Bao, M.O. Muench, J. Yu, and et al. Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection Proc. Natl. Acad. Sci. USA 111 2014 9591 9596
181. J.E. Young, J. Boulanger-Weill, D.A. Williams, G. Woodruff, F. Buen, A.C. Revilla, C. Herrera, M.A. Israel, S.H. Yuan, S.D. Edland, and L.S. Goldstein Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells Cell Stem Cell 16 2015 373 385
182. C.S. Young, M.R. Hicks, N.V. Ermolova, H. Nakano, M. Jan, S. Younesi, S. Karumbayaram, C. Kumagai-Cresse, D. Wang, J.A. Zack, and et al. A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells Cell Stem Cell 18 2016 533 540
183. J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, S. Tian, J. Nie, G.A. Jonsdottir, V. Ruotti, R. Stewart, and et al. Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
184. J. Yu, K. Hu, K. Smuga-Otto, S. Tian, R. Stewart, I.I. Slukvin, and J.A. Thomson Human induced pluripotent stem cells free of vector and transgene sequences Science 324 2009 797 801
185. Z. Yu, M. Ren, Z. Wang, B. Zhang, Y.S. Rong, R. Jiao, and G. Gao Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila Genetics 195 2013 289 291
186. C. Yu, Y. Liu, T. Ma, K. Liu, S. Xu, Y. Zhang, H. Liu, M. La Russa, M. Xie, S. Ding, and L.S. Qi Small molecules enhance CRISPR genome editing in pluripotent stem cells Cell Stem Cell 16 2015 142 147
187. K. Yusa Seamless genome editing in human pluripotent stem cells using custom endonuclease-based gene targeting and the piggyBac transposon Nat. Protoc. 8 2013 2061 2078
188. K. Yusa, S.T. Rashid, H. Strick-Marchand, I. Varela, P.Q. Liu, D.E. Paschon, E. Miranda, A. Ordóñez, N.R. Hannan, F.J. Rouhani, and et al. Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells Nature 478 2011 391 394
189. B. Zetsche, J.S. Gootenberg, O.O. Abudayyeh, I.M. Slaymaker, K.S. Makarova, P. Essletzbichler, S.E. Volz, J. Joung, J. van der Oost, A. Regev, and et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system Cell 163 2015 759 771
190. X.Y. Zhao, W. Li, Z. Lv, L. Liu, M. Tong, T. Hai, J. Hao, C.L. Guo, Q.W. Ma, L. Wang, and et al. iPS cells produce viable mice through tetraploid complementation Nature 461 2009 86 90
191. Y. Zhou, S. Zhu, C. Cai, P. Yuan, C. Li, Y. Huang, and W. Wei High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells Nature 509 2014 487 491
192. J. Zou, M.L. Maeder, P. Mali, S.M. Pruett-Miller, S. Thibodeau-Beganny, B.K. Chou, G. Chen, Z. Ye, I.H. Park, G.Q. Daley, and et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells Cell Stem Cell 5 2009 97 110
193. J. Zou, P. Mali, X. Huang, S.N. Dowey, and L. Cheng Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease Blood 118 2011 4599 4608
194. T.P. Zwaka, and J.A. Thomson Homologous recombination in human embryonic stem cells Nat. Biotechnol. 21 2003 319 321